News

DSM Celebrates Opening of New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia

DSM Pharmaceutical Products DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), today officially opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. This world-class operation in the Asia-Pacific region is an important growth area in DSM’s strategic development in the biopharmaceutical field. The facility was designed by an…

Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP Production Process for a Second Key Malaria Antigen

Pfenex Inc. Funding will be provided by Leidos through its Malaria Vaccine Production and Support Services Contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health San Diego, CA, October 29, 2013 – Pfenex Inc. today announced that Leidos Holdings, Inc. (NYSE: LDOS) (formerly SAIC) has awarded Pfenex a subcontract to develop a robust, scalable, cGMP-ready production process for large-scale production of the blood-stage malaria antigen Plasmodium falciparum reticulocyte-binding homolog 5 (Rh5).…

FUJIFILM Diosynth Biotechnologies Opens New Manufacturing Facility

FUJIFILM Diosynth Biotechnologies FUJIFILM DIOSYNTH BIOTECHNOLOGIES’ OPENS NEW MANUFACTURING FACILITY Billingham, Teesside, 2nd October 2013 : Fujifilm Diosynth Biotechnologies today formally opened its new mammalian cell culture cGMP manufacturing facility at a ceremony performed by HRH The Duke of Gloucester KG GCVO, a member of the UK Royal Family. The new facility, which has been built and commissioned in under 15 months, is the first facility of its kind in the UK, being purpose-built to utilise primarily single-use technologies for…

Gallus Strengthens Biologics CMO Business with Acquisition of Laureate

Gallus BioPharmaceuticals, LLC Gallus Strengthens Biologics CMO Business with Acquisition of Laureate (St. Louis, Missouri – October 1, 2013) – Gallus BioPharmaceuticals, LLC (Gallus), a leading biologics contract manufacturing organization (CMO), today announced its acquisition of Laureate Biopharmaceutical Services, Inc. (Laureate), a full service biologics CMO located in Princeton, New Jersey. This acquisition doubles Gallus’ process development (PD) and clinical drug substance manufacturing capacity, adds full protein characterization, testing and clinical fill-finish capability and offers a seamless development pathway for…

Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine

Pfenex Inc. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine Funding will be provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. San Diego, CA, October 1, 2013 – Pfenex Inc. today announced that the Department of…